X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (220) 220
1-deoxynojirimycin - analogs & derivatives (201) 201
humans (189) 189
male (127) 127
female (102) 102
1-deoxynojirimycin - therapeutic use (90) 90
adult (79) 79
middle aged (73) 73
animals (63) 63
1-deoxynojirimycin - adverse effects (61) 61
miglustat (59) 59
enzyme inhibitors - therapeutic use (57) 57
1-deoxynojirimycin - pharmacology (56) 56
glycoside hydrolase inhibitors (56) 56
n-butyldeoxynojirimycin (51) 51
endocrinology & metabolism (50) 50
1-deoxynojirimycin - administration & dosage (48) 48
diabetes mellitus, type 2 - drug therapy (47) 47
treatment outcome (47) 47
aged (46) 46
glucosamine - analogs & derivatives (45) 45
hypoglycemic agents - therapeutic use (41) 41
imino pyranoses (41) 41
pharmacology & pharmacy (41) 41
enzyme inhibitors - adverse effects (40) 40
mice (40) 40
gaucher disease - drug therapy (38) 38
genetics & heredity (36) 36
substrate reduction therapy (32) 32
glucosamine - therapeutic use (31) 31
medicine, research & experimental (31) 31
adolescent (30) 30
glucosamine - adverse effects (30) 30
miglitol (29) 29
acarbose (28) 28
blood glucose - metabolism (28) 28
double-blind method (28) 28
1-deoxynojirimycin (27) 27
care and treatment (27) 27
enzyme replacement therapy (27) 27
enzyme inhibitors - administration & dosage (26) 26
child (25) 25
enzymes (25) 25
time factors (25) 25
gaucher disease (24) 24
insulin - blood (24) 24
internal medicine (24) 24
biochemistry & molecular biology (23) 23
diabetes mellitus, type 2 - blood (23) 23
glucose (23) 23
niemann-pick disease, type c - drug therapy (23) 23
enzyme inhibitors - pharmacology (22) 22
hypoglycemic agents - adverse effects (22) 22
medicine & public health (22) 22
pharmacology (22) 22
1-deoxynojirimycin - pharmacokinetics (21) 21
alpha-glucosidase inhibitor (21) 21
diabetes (21) 21
efficacy (20) 20
glucosyltransferases - antagonists & inhibitors (20) 20
research (20) 20
young adult (20) 20
abridged index medicus (19) 19
diabetes mellitus (19) 19
hypoglycemic agents - pharmacology (19) 19
pediatrics (19) 19
type 2 diabetes (19) 19
analysis (18) 18
biosynthesis (18) 18
disease (18) 18
postprandial period (18) 18
child, preschool (17) 17
drug administration schedule (17) 17
glucosamine - pharmacology (17) 17
health aspects (17) 17
medicine (17) 17
rats (17) 17
administration, oral (16) 16
disease models, animal (16) 16
gangliosides (16) 16
hypoglycemic agents - administration & dosage (16) 16
physiological aspects (16) 16
safety (16) 16
blood glucose - analysis (15) 15
children (15) 15
glycated hemoglobin a - analysis (15) 15
lysosomal storage (15) 15
therapy (15) 15
blood glucose - drug effects (14) 14
dose-response relationship, drug (14) 14
gaucher-disease (14) 14
glucosylceramidase - therapeutic use (14) 14
medicine, general & internal (14) 14
pharmacokinetics (14) 14
drug therapy (13) 13
inhibitor (13) 13
mellitus (13) 13
prospective studies (13) 13
cross-over studies (12) 12
diagnosis (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medical Genetics, ISSN 0022-2593, 04/2017, Volume 54, Issue 4, pp. 288 - 296
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 761 - 765
We assessed the efficacy and safety of sitagliptin compared with α‐glucosidase inhibitor ( αGI ) in 120 of Japanese patients with type 2 diabetes mellitus (... 
type 2 diabetes | DPP‐IV | inhibitor | sulphonylureas | α‐glucosidase inhibitor | randomized trial | Type 2 diabetes | Randomized trial | α-glucosidase inhibitor | Sulphonylureas | DPP-IV inhibitor | VOGLIBOSE | MONOTHERAPY | HYPERGLYCEMIA | DOUBLE-BLIND TRIAL | alpha-glucosidase inhibitor | ENDOCRINOLOGY & METABOLISM | MELLITUS | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Hypoglycemia - prevention & control | 1-Deoxynojirimycin - therapeutic use | Drug Therapy, Combination - adverse effects | Inositol - therapeutic use | Inositol - adverse effects | 1-Deoxynojirimycin - analogs & derivatives | Female | 1-Deoxynojirimycin - adverse effects | Sitagliptin Phosphate | Hypoglycemia - chemically induced | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Japan | Sulfonylurea Compounds - therapeutic use | Inositol - analogs & derivatives | Diabetes Mellitus, Type 2 - blood | Gastrointestinal Agents - therapeutic use | Pyrazines - adverse effects | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | alpha-Glucosidases - metabolism | alpha-Glucosidases - chemistry | Index Medicus
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 6, pp. 545 - 555
Journal Article
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 02/2018, Volume 68, pp. 173 - 179
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0121662 - e0121662
Journal Article
Journal Article
Journal Article